Exhibit 10.14
Employment Agreement
This Agreement (the “Agreement”), effective as of May 25, 2023, is entered into by and between GAVIN MACBEATH (the “Executive” or “you”) and TScan Therapeutics, Inc. (the “Company”), a Delaware corporation and replaces and supersedes all other employment agreements and understandings between the Executive and Company except as otherwise set forth herein.
During his Employment, the Executive shall be eligible for:
-2-
-3-
-4-
-5-
A Resignation for Good Reason shall not be deemed to have occurred unless the Executive gives the Company written notice of the condition within 60 days after the condition comes into existence and the Company fails to remedy the condition within 30 days after receiving the Executive’s written notice.
-6-
-7-
-8-
IN WITNESS WHEREOF, each of the parties has executed this Agreement, in the case of the Company by its duly authorized officer, effective as of the day and year first above written.
TScan Therapeutics, Inc.
Signature: /s/ Zoran Zdraveski
Title: CLO
Date: 2/6/2024
Executive
/s/ Gavin MacBeath
Gavin MacBeath
Date: 2/6/2024
Exhibit A: Proprietary Information and Inventions Agreement
-9-